Thymoma Type B — Trials

Thymoma Type B — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04710628	Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents(PECATI)	completed	Phase 2	43	MedSIROTHER	3	Feb 19, 2026	clinicaltrials
NCT02307500	Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy(RESOUND)	completed	Phase 2	82	Istituto Clinico HumanitasOTHER	1	Sep 10, 2022	clinicaltrials

Data updated 22 days agoSource updated Feb 19, 2026source: clinicaltrials